Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer
ConclusionFemale sex, overweight, and initial biliary stent insertion were independent risk factors for the occurrence of FN in patients with unresectable PC treated with FOLFIRINOX.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Obesity | Pancreas | Pancreatic Cancer | Statistics | Study